02696.HK 财务： Shanghai Henlius Biotech, Inc. AI 分析

Q: 技术分析指标如何适用于 02696.HK？

根据技术分析，Shanghai Henlius Biotech, Inc. 的综合信号为 Buy。Shanghai Henlius Biotech, Inc. 有 3 个买入信号，2 个中性信号和 2 个卖出信号。

Q: 02696.HK 的斐波那契回调水平是多少？

Shanghai Henlius Biotech, Inc. 的斐波那契回调水平是 在 61.8% 和 78.6% 之间。

Q: Shanghai Henlius Biotech, Inc. 的 RSI 是多少？

Shanghai Henlius Biotech, Inc. 的 RSI 目前为 66.11，表明处于 中立 状态

Q: Shanghai Henlius Biotech, Inc. 接下来 12 个月的价格是多少？

Shanghai Henlius Biotech, Inc. 02696.HK 接下来 12 个月的价格预计为 $0。

Q: Shanghai Henlius Biotech, Inc. 预计会涨到多高？

据华尔街分析师称，Shanghai Henlius Biotech, Inc. 预计将达到 $0 的高预测值。

主页

股票

02696.HK

预测

HENLIUS (02696.HK)

Shanghai Henlius Biotech, Inc.

HK$68.25

1.26%

$0.84

休市： Jan 16, 16:00:00 HKT

关键数据

前收盘价

$67.4

开盘价

$67.4

当日区间

$66.55 - $69.9

52周范围

$15.2 - $92

交易量

384.2K

平均成交量

1.1M

每股收益（TTM）

1.69

股息收益率

市值

$11.1B

什么是 HENLIUS？

Shanghai Henlius Biotech, Inc. engages in the production and sale of monoclonal antibody (mAb) drugs and the provision of related consultation and technical services, and the transfer of its own technology. The company is headquartered in Shanghai, Shanghai and currently employs 3,537 full-time employees. The company went IPO on 2019-09-25. The Company’s main products include HANQUYOU (trastuzumab for injection), HANNAIJIA (neratinib maleate), HANSIZHUANG (serplulimab injection), HANLIKANG (rituximab injection), HANDAYUAN (adalimumab injection), HANBEITAI (bevacizumab injection) and others. The Company’s products are mainly used in the treatment of adjuvant breast cancer, metastatic breast cancer, metastatic gastric cancer, metastatic non-squamous non-small cell lung cancer, polyarticular juvenile idiopathic arthritis and others. The firm mainly operates its businesses in the domestic and overseas markets.

功能特性

交易策略

资源

市场

02696.HK 股价预测摘要

02696.HK stock price ended at $68.25 on 星期五, after rising 1.26%

On the latest trading day Jan 16, 2026, the stock price of 02696.HK rose by 1.26%, climbing from $67.40 to $68.25. During the session, the stock saw a volatility of 5.03%, with prices oscillating between a daily low of $66.55 and a high of $69.90. Notably, trading volume dropped by 123.0K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 381.1K shares were traded, equating to a market value of approximately $11.1B.

02696.HK 技术面信号

技术面信号摘要

购买信号 3

中性信号 2

卖出信号 2

Strong Sell

Sell

Neutral

Buy

Strong Buy

02696.HK目前显示3个买入信号和2个卖出信号。该股票自12:00 AM以来一直处于上升趋势状态，在此期间价格总变动为1.56%。总体而言，技术指标显示中期前景为Buy。

02696.HK 的看涨/看跌信号

我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 02696.HK 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。

后续问题

技术分析指标如何适用于 02696.HK？



02696.HK 的斐波那契回调水平是多少？



Shanghai Henlius Biotech, Inc. 的 RSI 是多少？



Shanghai Henlius Biotech, Inc. 接下来 12 个月的价格是多少？



Shanghai Henlius Biotech, Inc. 预计会涨到多高？



Shanghai Henlius Biotech, Inc.（02696.HK）价格

02696.HK 股价走势图